68Ga-PSMA PET/CT for primary lymph node and distant metastasis NM staging of high-risk prostate cancer
S Klingenberg, MR Jochumsen, BP Ulhøi… - Journal of Nuclear …, 2021 - Soc Nuclear Med
With the largest high-risk prostate cancer (PCa) cohort to date undergoing 68Ga-prostate-
specific membrane antigen (PSMA) PET/CT primary staging, we aimed to, first, characterize …
specific membrane antigen (PSMA) PET/CT primary staging, we aimed to, first, characterize …
Risk of metastatic disease on 68gallium‐prostate‐specific membrane antigen positron emission tomography/computed tomography scan for primary staging of 1253 …
JW Yaxley, S Raveenthiran, FX Nouhaud… - BJU …, 2019 - Wiley Online Library
Objective To determine the number of men with 68gallium‐prostate‐specific membrane
antigen positron emission tomography/computed tomography (68Ga‐PSMA PET/CT) avid …
antigen positron emission tomography/computed tomography (68Ga‐PSMA PET/CT) avid …
Yield of bone scintigraphy for the detection of metastatic disease in treatment-naive prostate cancer: a systematic review and meta-analysis
CH Suh, AB Shinagare, AM Westenfield, NH Ramaiya… - Clinical Radiology, 2018 - Elsevier
Aim To evaluate the yield of staging bone scintigraphy in patients with treatment-naive
prostate cancer. Materials and methods A computerised search of the MEDLINE and …
prostate cancer. Materials and methods A computerised search of the MEDLINE and …
Comparing 99mTc-PSMA to 99mTc-MDP in prostate cancer staging of the skeletal system
Comparing 99mTc-PSMA to 99mTc-MDP in Prostate Cancer Staging... : Clinical Nuclear
Medicine Comparing 99mTc-PSMA to 99mTc-MDP in Prostate Cancer Staging of the Skeletal …
Medicine Comparing 99mTc-PSMA to 99mTc-MDP in Prostate Cancer Staging of the Skeletal …
Prostate-specific membrane antigen for prostate cancer theranostics: from imaging to targeted therapy
F Arsenault, JM Beauregard… - Current Opinion in …, 2018 - journals.lww.com
PSMA-targeted tracers have shown unprecedented accuracy to stage and restage PCa
using PET/CT. Given their specific biodistribution toward PCa tissue, PSMA RLT now offers …
using PET/CT. Given their specific biodistribution toward PCa tissue, PSMA RLT now offers …
[PDF][PDF] Appropriate use criteria for bone scintigraphy in prostate and breast cancer: summary and excerpts
KJ Donohoe, EJ Cohen, F Giammarile, E Grady… - 2017 - Soc Nuclear Med
Nuclear medicine imaging studies are essential to the diagnosis and management of many
diseases, including neoplastic disease (1). Modern imaging studies allow noninvasive …
diseases, including neoplastic disease (1). Modern imaging studies allow noninvasive …
Prostate cancer bone metastases on staging prostate MRI: prevalence and clinical features associated with their diagnosis
Purpose Bone lesions on prostate MRI often raise concern about metastases. This study
aimed to evaluate the prevalence of bone metastases on staging prostate MRI and evaluate …
aimed to evaluate the prevalence of bone metastases on staging prostate MRI and evaluate …
18F-fluciclovine PET/CT detection of biochemical recurrent prostate cancer in patients with PSA levels< 2.00 ng/mL
D Garza, A Kandathil, Y Xi… - Nuclear Medicine …, 2021 - journals.lww.com
Objective To establish the detection rate of prostate cancer recurrence following definitive
therapy by 18 F-fluciclovine PET/computed tomography (CT) in patients with biochemical …
therapy by 18 F-fluciclovine PET/computed tomography (CT) in patients with biochemical …
Safely omitting bone isotope scans in a cohort of grade group 2 prostate cancer
A Mustaffa, S Emara - The Prostate, 2023 - Wiley Online Library
Objective A retrospective review conducted in our urology unit to assess the efficiency for
requesting bone scans for newly diagnosed prostate cancer patients, aiming to minimize …
requesting bone scans for newly diagnosed prostate cancer patients, aiming to minimize …
[PDF][PDF] Association of PSA with bone scan in carcinoma prostate
KC Rohra, RH Mangrio, AA Shaikh, B Suria… - Rawal Medical …, 2022 - rmj.org.pk
Objective: To see the relation of PSA> 20 ng/dl with bone metastasis. Methodology: This is
prospective study includes fifty patient who were newly diagnosed with PSA> 20 ng/dl …
prospective study includes fifty patient who were newly diagnosed with PSA> 20 ng/dl …